136818-64-9 Usage
Uses
Used in Pharmaceutical Research:
Methyl 5-fluoro-6-methoxy-1H-indole-2-carboxylate is used as a building block for the development of new drugs and biologically active compounds. Its unique structure and properties make it a promising candidate for the discovery of novel therapeutic agents.
Used in Medicinal Chemistry Applications:
The presence of a fluoro group in the molecule makes Methyl 5-fluoro-6-methoxy-1H-indole-2-carboxylate particularly interesting for medicinal chemistry applications. Fluorine is known to enhance the pharmacokinetic and pharmacodynamic properties of drugs, making Methyl 5-fluoro-6-Methoxy-1H-indole-2-carboxylate a valuable asset in the design and synthesis of new pharmaceuticals.
Used in Organic Synthesis:
Methyl 5-fluoro-6-methoxy-1H-indole-2-carboxylate is also used in organic synthesis, where its unique structure and properties can be leveraged to create a variety of new compounds with potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 136818-64-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,6,8,1 and 8 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 136818-64:
(8*1)+(7*3)+(6*6)+(5*8)+(4*1)+(3*8)+(2*6)+(1*4)=149
149 % 10 = 9
So 136818-64-9 is a valid CAS Registry Number.
136818-64-9Relevant academic research and scientific papers
QUINUCLIDINES FOR MODULATING ALPHA 7 ACTIVITY
-
Paragraph 0321, (2016/02/29)
Provided are substituted quinuclidine compounds, pharmaceutical compositions comprising such compounds, and methods of modulating α7 nicotinic acetylcholine receptors and treating neurological disorders using such compounds.
Anti-aids piperazines
-
, (2008/06/13)
The present invention includes diaromatic substituted heterocyclic compounds (III) STR1 which are useful in treating individuals infected with the HIV virus. The invention includes certain previously generically disclosed anti-AIDS piperazinyl compounds (V) and a method of treating HIV infected individuals with the indoles of formula (V) and the anti-AIDS amines (X).
